Lilly(Eli) & Company
NYSE: LLY
$887.16
+$1.61 (+0.2%)
Closing Price on October 4, 2024
LLY Articles
ThinkstockThe number of companies paying dividends in the S&P 500 is at a 15-year high. According to FactSet, just over 80 companies in the index do not pay dividends. Paying dividends has become...
Published:
Last Updated:
ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the top...
Published:
Last Updated:
ThinkstockThe second-quarter earnings parade has all but come to a end. One conclusion that is painfully obvious to the equity strategy team at Credit Suisse is that many companies beat earnings only...
Published:
Last Updated:
courtesy of Sprint Corp.In the past 30 years, the hedge fund industry has shown phenomenal growth. Initially formed as true “hedges” against conventional investing, they morphed into vehicles for...
Published:
Last Updated:
ThinkstockIntrexon Corp. has filed its paperwork with the Securities and Exchange Commission to allow the company to come public in an initial public offering. No formal financial terms have been set...
Published:
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, May 28, 2013. They include Eli Lilly, W.R. Grace, Intelsat and GlaxoSmithKline.
Published:
Last Updated:
ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own or sell as the market chugs higher. One strategy for investors to consider is keep a weighting...
Published:
Last Updated:
Wikimedia CommonsYesterday’s announcement by Pfizer Inc. (NYSE: PFE) that it would begin selling its blockbuster Viagra drug online directly to patients is a genuinely ground-breaking deal. The big...
Published:
Last Updated:
ThinkstockNow that Pfizer Inc. (NYSE: PFE) has started to sell Viagra online at Viagra.com, can Cialis.com and Levitra.com be far behind? These two other drugs face the same black market trouble...
Published:
ThinkstockThe world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating billions upon billions in annual sales in the United States alone. Some...
Published:
Last Updated:
courtesy of Facebook Inc.Martha Stewart Omnimedia Inc. (NYSE: MSO) is unable to get a court to dismiss charges by Macy’s Inc. (NYSE: M) that it has exclusive rights to some of her products....
Published:
ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or at a minimum...
Published:
Last Updated:
ThinkstockAccording to the Center for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke,...
Published:
Last Updated:
ThinkstockThe U.S. Food and Drug Administration (FDA) last night rejected an application from Johnson & Johnson (NYSE: JNJ) and Germany’s Bayer A.G. to extend the use of the two companies’...
Published:
Last Updated:
ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary event that...
Published:
Last Updated: